←
Jose Orgaz553 posts
Jose Orgaz avatar

Jose Orgaz

@JoseOrgaz2

Cell biologist interested in melanoma research. Group Leader @ Instituto de Investigaciones Biomedicas Alberto Sols CSIC-UAM @IIBmCSICUAM. @jlorgaz.bsky.social

◷ Joined December 2019▧ 4 Photos and videos
Jose Orgaz avatar
Jose Orgaz@JoseOrgaz2·2 Feb 2022

Interested in the cytoskeleton and therapy resistance, in particular in melanoma? Have a look at our review just published mdpi.com/2073-4409/11/3/518 @IIBmCSICUAM Thanks so much @CicMechano for the invitation!

NEJM avatar
⟳ Jose Orgaz retweeted
NEJM@NEJM·May 31

Presented at #ASCO26: Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM @ASCO

Post attachment
Vicky Sanz-Moreno avatar
⟳ Jose Orgaz retweeted
Vicky Sanz-Moreno@VickySanzMoreno·May 29

Delighted to share our latest piece on our favourite cancer cells! Well done @RitobrataGhose 👏 Amoeboid cancer cells at a glance journals.biologists.com/jcs/…

eriksahailab avatar
⟳ Jose Orgaz retweeted
eriksahailab@eriksahailab·19 Jun 2024

The phrase ‘metastasis accounts for 90% of cancer deaths’ is one of the most widely used in cancer research, yet it is overly simplistic & imprecise. Here we dig deeper into the events leading to cancer mortality nature.com/articles/s41568-0… 1/2